Bank Pictet & Cie (Europe)’s Immune Pharmaceuticals Inc. IMNP Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio IMNP Stock Details IMNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-645	Closed	-$15K	–	163
2015 Q3	$15K	Hold	645	–	–	﹤0.01%	146
2015 Q2	$25K	Hold	645	–	–	0.02%	86
2015 Q1	$23K	Hold	645	–	–	0.01%	156
2014 Q4	$25K	Hold	645	–	–	0.01%	152
2014 Q3	$45K	Buy	+645	New	+$45.9K	0.01%	144

Other funds holding IMNP

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IFS

Ifrah Financial Services Little Rock, Arkansas $409M AUM 28.15% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s IMNP Position: Q4 2015 in Review

Bank Pictet & Cie (Europe) sold out of Immune Pharmaceuticals Inc. (IMNP) in Q4 2015, closing a stake of 645 shares — an estimated $15K sold.

Bank Pictet & Cie (Europe) first reported a position in IMNP in Q3 2014 and held it in 5 quarters. The position peaked at $45K in Q3 2014. 15 funds tracked by Wall St. Rank hold IMNP as of Q4 2015.

Bank Pictet & Cie (Europe) reported no remaining Immune Pharmaceuticals Inc. position as of Q4 2015 after selling out during the quarter.
Bank Pictet & Cie (Europe) sold 645 Immune Pharmaceuticals Inc. shares in Q4 2015, an estimated $15K.
Bank Pictet & Cie (Europe) first reported a position in Immune Pharmaceuticals Inc. in Q3 2014 and held it in 5 quarters.
Bank Pictet & Cie (Europe)'s Immune Pharmaceuticals Inc. position peaked at $45K in Q3 2014.
15 funds tracked by Wall St. Rank held Immune Pharmaceuticals Inc. as of Q4 2015.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2015, filed 3 Feb 2016.